Antimicrobial therapy of experimental intraabdominal sepsis

William M. Weinstein, Andrew B. Onderdonk, John G. Bartlett, Thomas J. Louie, Sherwood L. Gorbach

Research output: Contribution to journalArticle

Abstract

Septic complications of colonic perforation involve multiple bacteria derived from the intestinal flora. This type of mixed intraabdominal infection was produced experimentally by insertion of a standardized inoculum of rat colonic contents into the peritoneal cavity of male Wistar rats. The respective roles of coliforms and anaerobic bacteria were then studied by use of selective antimicrobial therapy (with gentamicin and clindamycin). Untreated rats had a two stage disease. Initially, there was an acute peritonitis associated with a 37% mortality rate; all animals that survived developed indolent intraabdominal abscesses. Treatment with gentamicin reduced the acute mortality rate to 4%, but 98% of the survivors had abscesses. Clindamycin therapy was associated with a 35% mortality rate, but the incidence of intraabdominal abscess was only 5%. A combination of gentamicin and clindamycin yielded the salutary effects of each agent - 7% mortality and 6% incidence of abscesses. These studies, in concert with bacteriological findings, suggest that coliforms caused early mortality while anaerobes were primarily responsible for the late complication of intraabdominal abscess formation.

Original languageEnglish (US)
Pages (from-to)282-286
Number of pages5
JournalUnknown Journal
Volume132
Issue number3
DOIs
StatePublished - Jan 1 1975
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Antimicrobial therapy of experimental intraabdominal sepsis'. Together they form a unique fingerprint.

  • Cite this

    Weinstein, W. M., Onderdonk, A. B., Bartlett, J. G., Louie, T. J., & Gorbach, S. L. (1975). Antimicrobial therapy of experimental intraabdominal sepsis. Unknown Journal, 132(3), 282-286. https://doi.org/10.1093/infdis/132.3.282